Aamorb Pharmaceuticals Private Limited
Aamorb Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2006 and based in Madhya Pradesh, India. Aamorb Pharmaceuticals Private Limited operates in Forestry (NIC 02423) with authorized capital of ₹24.00 L and paid-up capital of ₹20.00 L. For 2017-18, the company reported revenue of ₹23.60 Cr and profit after tax of ₹1.06 Cr. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aamorb Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 521623684 | State Bank of India(Bank) | ₹2.09 Cr | 04 Jul 2022 | Open |
| 144958902 | Axis Bank Ltd(Bank) | ₹2.67 Cr | 27 Jan 2020 | Satisfied |
| 307375042 | State Bank of India(Bank) | ₹11.56 Cr | 19 Sep 2020 | Satisfied |
| 372380084 | HDFC Bank Ltd(Bank) | ₹11.51 Cr | 04 Jul 2022 | Satisfied |
Charge IDs, lenders & amounts for Aamorb Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2017-18 | — |
Detailed Financials
1 FYs| Line item | 2017-18 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹19.30 Cr | +13.3% | +22.0% | +14.7% |
| Profit after Tax | ₹1.57 Cr | -3.9% | +24.4% | +15.4% |
| Net Worth | ₹6.48 Cr | -8.8% | +19.3% | +21.8% |
| Employees | 378 | +3.3% | +12.7% | +21.4% |
Audited financials & ratios for Aamorb Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +4.49% | — | +43.50% | +12.49% | 3.48 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,75,93,417 | 63.86% |
| Institutional Investors | 1 | 51,45,526 | 11.91% |
| Public & Others | 42 | 1,04,72,668 | 24.24% |
Promoter, institutional & public holding for Aamorb Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
150 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.